The stock of Critical Outcome Technologies Inc. (CVE:COT) is a huge mover today! About 57,000 shares traded hands. Critical Outcome Technologies Inc. (CVE:COT) has risen 6.00% since October 5, 2016 and is uptrending. It has outperformed by 4.91% the S&P500.
The move comes after 7 months negative chart setup for the $73.07M company. It was reported on Nov, 4 by Barchart.com. We have $0.45 PT which if reached, will make CVE:COT worth $8.04M less.
More notable recent Critical Outcome Technologies Inc. (CVE:COT) news were published by: Business.Financialpost.com which released: “Podcast: Critical Outcome Technologies CEO Wayne Danter on new ways to develop …” on May 31, 2016, also Marketwired.com with their article: “Critical Outcome Technologies Reports Year-End Financial & Operating Results” published on August 03, 2016, Marketwired.com published: “Critical Outcome Technologies Receives $1.6M From Warrant Exercises” on June 03, 2016. More interesting news about Critical Outcome Technologies Inc. (CVE:COT) were released by: Marketwired.com and their article: “Critical Outcome Technologies Announces Next Clinical Candidate, COTI-219 …” published on October 11, 2016 as well as Marketwired.com‘s news article titled: “Critical Outcome Technologies Provides Update on Recent Achievements and …” with publication date: October 14, 2016.
Critical Outcome Technologies Inc. is a clinical-stage biopharmaceutical company. The company has a market cap of $73.07 million. The Firm is engaged in drug discovery and development. It currently has negative earnings. The Firm uses machine learning to develop targeted therapies thereby managing the timeline and cost of getting new drug therapies to market.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.